Chemoinformaics analysis of 11-Methoxy-19-(R)- hydroxygelselegine
| Molecular Weight | 404.463 | nRot | 4 |
| Heavy Atom Molecular Weight | 376.239 | nRig | 24 |
| Exact Molecular Weight | 404.195 | nRing | 6 |
| Solubility: LogS | -2.318 | nHRing | 4 |
| Solubility: LogP | 0.669 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 60.7522 |
| nHD | 3 | BPOL | 35.3058 |
| QED | 0.666 |
| Synth | 6.619 |
| Natural Product Likeliness | 1.927 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.054 |
| Pgp-sub | 0.476 |
| HIA | 0.599 |
| CACO-2 | -5.219 |
| MDCK | 0.000014 |
| BBB | 0.16 |
| PPB | 0.0824525 |
| VDSS | 0.808 |
| FU | 0.870688 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.666 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.24 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.534 |
| CYP3a4-inh | 0.134 |
| CYP3a4-sub | 0.909 |
| CL | 5.413 |
| T12 | 0.151 |
| hERG | 0.271 |
| Ames | 0.523 |
| ROA | 0.159 |
| SkinSen | 0.354 |
| Carcinogencity | 0.597 |
| EI | 0.004 |
| Respiratory | 0.584 |
| NR-Aromatase | 0.926 |
| Antiviral | Yes |
| Prediction | 0.605563 |